2018;72:434 47. S4.5.1-33. Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of car- diovascular disease with pravastatin in Japan (MEGA Study): a pro- spective randomised controlled trial. Lancet. 2006;368:1155 63. S4.5.1-34. Kimura T, Inoue T, Taguchi I, et al. Does high-intensity pitavastatin therapy further improve clinical outcomes? The REAL-CAD study CLINICAL STATEMENTS AND GUIDELINES in 13054 patients with stable coronary artery disease. Circulation 2017:136;e450. S4.5.1-35. Birmingham BK, Bujac SR, Elsby R, et al. Rosuvastatin pharmacoki- netics and pharmacogenetics in Caucasian and Asian subjects resid- ing in the United States. Eur J Clin Pharmacol. 2015;71:329 40. S4.5.1-36. Lee E, Ryan S, Birmingham B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005;78:330 41. S4.5.1-37. Liao JK. Safety and efficacy of statins in Asians. Am J Cardiol. 2007;99:410 4. S4.5.1-38. Lloret R, Ycas J, Stein M, et al. Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial) Am J Cardiol. 2006;98:768 73. S4.5.1-39. George MD, McGill NK, Baker JF. Creatine kinase in the US popula- tion: Impact of demographics, comorbidities, and body composition on the normal range. Medicine (Baltimore). 2016;95:e4344. S4.5.2-1. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce ath- erosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1 45. S4.5.2-2. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213 9. S4.5.2-3. Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama. 2007;298:299 308. S4.5.2-4. 